Programmed cell death 4 inhibits leptin-induced breast cancer cell invasion

Oncology Reports

Volumn 27, Issue 3, 2012, Pages 861-866

  González Villasana, Vianey ^a,b   Nieves Alicea, René ^c   McMurtry, Vanity ^b   Gutiérrez Puente, Yolanda ^a   Tari, Ana M ^b,d  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Breast cancer invasion; Leptin; Programmed cell death 4; Tissue inhibitor of metalloproteinase 2

Indexed keywords

LEPTIN; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROGRAMMED CELL DEATH 4; SMALL INTERFERING RNA; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER INVASION; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; METASTASIS INHIBITION; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH;

APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEPTIN; MAP KINASE SIGNALING SYSTEM; NEOPLASM INVASIVENESS; PHOSPHORYLATION; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFECTION;

EID: 84856287365     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1600     Document Type: Article

References (29)

1. Verreault R, Brisson J, Deschenes L and Naud F: Body weight and prognostic indicators in breast cancer. Modifying effect of estrogen receptors. Am J Epidemiol 129: 260-268, 1989. (Pubitemid 19046993)
2. Giuffrida D, Lupo L, La Porta GA, et al: Relation between steroid receptor status and body weight in breast cancer patients. Eur J Cancer 28: 112-115, 1992.
3. Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS and Moorman PG: Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 151: 703-714, 2000. (Pubitemid 30463592)
4. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L and Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432, 1994. (Pubitemid 24365442)
5. Sinha MK, Opentanova I, Ohannesian JP, et al: Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 98: 1277-1282, 1996. (Pubitemid 26322051)
6. McGregor GP, Desaga JF, Ehlenz K, et al: Radiommunological measurement of leptin in plasma of obese and diabetic human subjects. Endocrinology 137: 1501-1504, 1996. (Pubitemid 26098620)
7. Ishikawa M, Kitayama J and Nagawa H: Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10: 4325-4331, 2004. (Pubitemid 38878870)
8. Miyoshi Y, Funahashi T, Tanaka S, et al: High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer 118: 1414-1419, 2006.
9. Caldefie-Chezet F, Damez M, de Latour M, et al: Leptin: a proliferative factor for breast cancer? Study on human ductal carcinoma. Biochem Biophys Res Commun 334: 737-741, 2005. (Pubitemid 41033183)
10. Garofalo C, Koda M, Cascio S, et al: Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res 12: 1447-1453, 2006.
11. Revillion F, Charlier M, Lhotellier V, et al: Messenger RNA expression of leptin and leptin receptors and their prognostic value in 322 human primary breast cancers. Clin Cancer Res 12: 2088-2094, 2006.
12. Cleary MP, Juneja SC, Phillips FC, Hu X, Grande JP and Maihle NJ: Leptin receptor-deficient MMTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop oncogene-induced mammary tumors. Exp Biol Med (Maywood) 229: 182-193, 2004. (Pubitemid 38146562)
13. Gonzalez RR, Cherfils S, Escobar M, et al: Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem 281: 26320-26328, 2006. (Pubitemid 44401840)
14. McMurtry V, Simeone AM, Nieves-Alicea R and Tari AM: Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells. Clin Exp Metastasis 26: 197-204, 2009.
15. Catalano S, Marsico S, Giordano C, et al: Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J Biol Chem 278: 28668-28676, 2003. (Pubitemid 36935773)
16. Catalano S, Mauro L, Marsico S, et al: Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells. J Biol Chem 279: 19908-19915, 2004. (Pubitemid 38623433)
17. Garofalo C, Sisci D and Surmacz E: Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells. Clin Cancer Res 10: 6466-6475, 2004. (Pubitemid 39346542)
18. Jansen AP, Camalier CE, Stark C and Colburn NH: Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol Cancer Ther 3: 103-110, 2004. (Pubitemid 39193684)
19. Nieves-Alicea R, Colburn NH, Simeone AM and Tari AM: Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression. Breast Cancer Res Treat 114: 203-209, 2009.
20. Yin N, Wang D, Zhang H, et al: Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res 64: 5870-5875, 2004. (Pubitemid 39095588)
21. Chen C, Chang YC, Liu CL, Chang KJ and Guo IC: Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1. Breast Cancer Res Treat 98: 121-132, 2006. (Pubitemid 44050760)
22. Saxena NK, Sharma D, Ding X, et al: Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res 67: 2497-2507, 2007. (Pubitemid 46548934)
23. Ray A, Nkhata KJ and Cleary MP: Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status. Int J Oncol 30: 1499-1509, 2007.
24. Jiang H, Yu J, Guo H, Song H and Chen S: Upregulation of survivin by leptin/STAT3 signaling in MCF-7 cells. Biochem Biophys Res Commun 368: 1-5, 2008.
25. Calle EE, Rodriguez C, Walker-Thurmond K and Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638, 2003. (Pubitemid 36459468)
26. Wen YH, Shi X, Chiriboga L, Matsahashi S, Yee H and Afonja O: Alterations in the expression of PDCD4 in ductal carcinoma of the breast. Oncol Rep 18: 1387-1393, 2007.
27. Sharma D, Saxena NK, Vertino PM and Anania FA: Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocr Relat Cancer 13: 629-640, 2006. (Pubitemid 43886682)
28. Yang HS, Matthews CP, Clair T, et al: Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 26: 1297-1306, 2006. (Pubitemid 43202557)
29. Bitomsky N, Bohm M and Klempnauer KH: Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene 23: 7484-7493, 2004. (Pubitemid 39389690)